Search Results - "Punyawudho, Baralee"

Refine Results
  1. 1

    Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic–Pharmacogenetic Model of HIV-infected Patients in Thailand by Chaivichacharn, Piyawat, Avihingsanon, Anchalee, Manosuthi, Weerawat, Ubolyam, Sasiwimol, Tongkobpetch, Siraprapa, Shotelersuk, Vorasuk, Punyawudho, Baralee

    Published in Clinical therapeutics (01-07-2020)
    “…Efavirenz exhibits high interindividual variability in plasma concentrations, leading to unpredictable efficacy and toxicity. Polymorphism of CYP2B6 516G > T…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant Staphylococcus aureus Infections by Chattaweelarp, Thanawat, Changpradub, Dhitiwat, Punyawudho, Baralee, Thunyaharn, Sudaluck, Santimaleeworagun, Wichai

    Published in Antibiotics (Basel) (01-10-2020)
    “…Optimal early vancomycin target exposure remains controversial. To clarify the therapeutic exposure range, we investigated the association between vancomycin…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients by Punyawudho, Baralee, Singkham, Noppaket, Thammajaruk, Narukjaporn, Dalodom, Theera, Kerr, Stephen J, Burger, David M, Ruxrungtham, Kiat

    Published in Expert review of clinical pharmacology (01-12-2016)
    “…Therapeutic drug monitoring (TDM) may be beneficial when applied to antiretroviral (ARV). Even though TDM can be a valuable strategy in HIV management, its…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Population pharmacokinetics of nevirapine in Thai HIV-infected patients by Wattanakul, Thanaporn, Avihingsanon, Anchalee, Manosuthi, Weerawat, Punyawudho, Baralee

    Published in Antiviral therapy (01-01-2014)
    “…Nevirapine-based antiretroviral therapy is widely used as a first-line treatment for HIV-infected patients in resource-limited settings. Nevirapine plasma…”
    Get more information
    Journal Article
  9. 9

    Population Pharmacokinetics of Carbamazepine in Elderly Patients by PUNYAWUDHO, Baralee, RAMSAY, Eugene R, BRUNDAGE, Richard C, MACIAS, Flavia M, COLLINS, Joseph F, BIRNBAUM, Angela K

    Published in Therapeutic drug monitoring (01-04-2012)
    “…Carbamazepine is a commonly used antiepileptic drug in elderly patients. This study analyzed prospective data collected as part of a randomized, double-blinded…”
    Get full text
    Journal Article
  10. 10

    Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients by Punyawudho, Baralee, Lertdumrongluk, Paungpaga, Somparn, Poorichaya, Kittanamongkolchai, Wonngarm, Traitanon, Opas, Avihingsanon, Yingyos, Vadcharavivad, Somratai

    “…Mycophenolic acid (MPA) has become the first-line drug therapy for proliferative lupus nephritis, a common and serious complication of systemic lupus…”
    Get full text
    Journal Article
  11. 11

    Characterization of the Time Course of Carbamazepine Deinduction by an Enzyme Turnover Model by Punyawudho, Baralee, Cloyd, James C., Leppik, Ilo E., Ramsay, R. Eugene, Marino, Susan E., Pennell, Page B., White, James R., Birnbaum, Angela K.

    Published in Clinical pharmacokinetics (01-01-2009)
    “…Background and objective: Carbamazepine is a potent inducer of drug metabolizing enzymes, which results in a number of clinically significant drug-drug…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients by Rungtivasuwan, Kanokrat, Avihingsanon, Anchalee, Thammajaruk, Narukjaporn, Mitruk, Siwaporn, Burger, David M, Ruxrungtham, Kiat, Punyawudho, Baralee, Pengsuparp, Thitima

    Published in Antimicrobial agents and chemotherapy (01-06-2015)
    “…Tenofovir (TFV) is eliminated by renal excretion, which is mediated through multidrug-resistant protein 2 (MRP2) and MRP4, encoded by ABCC2 and ABCC4,…”
    Get full text
    Journal Article
  14. 14

    Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients by Singkham, Noppaket, Towanabut, Somchai, Lertkachatarn, Surang, Punyawudho, Baralee

    Published in European journal of clinical pharmacology (01-06-2013)
    “…Background and objectives: A high inter-individual variability in the pharmacokinetics of lamotrigine has been observed. Lamotrigine is primarily metabolized…”
    Get full text
    Journal Article
  15. 15

    Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in thai HIV-infected patients by Punyawudho, Baralee, Thammajaruk, Narukjaporn, Ruxrungtham, Kiat, Avihingsanon, Anchalee

    “…Highlights • Population mean clearance (CL/ F ) of ATV in Thai HIV-infected patients was lower than reported values in other ethnicities. • ATV CL/F was…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients by Rungtivasuwan, Kanokrat, Avihingsanon, Anchalee, Thammajaruk, Narukjaporn, Mitruk, Siwaporn, Burger, David M, Ruxrungtham, Kiat, Sukasem, Chonlaphat, Punyawudho, Baralee

    Published in Pharmacogenomics (01-11-2017)
    “…To develop a population pharmacokinetic model and identify sources of variability, genetic and nongenetic factors, of tenofovir. The and polymorphisms were…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients by Singkham, Noppaket, Avihingsanon, Anchalee, Thammajaruk, Narukjaporn, Ruxrungtham, Kiat, Bunupuradah, Torsak, Kiertiburanakul, Sasisopin, Chetchotisakd, Ploenchan, Burger, David M, Emery, Sean, Punyawudho, Baralee

    Published in Pharmacogenomics (01-05-2019)
    “…To evaluate the influence of genetic polymorphisms on plasma trough concentrations of atazanavir (ATV) and ritonavir (RTV). The concentration-to-dose ratios…”
    Get full text
    Journal Article